Related Experiment Video
Updated: Mar 8, 2026
11:21
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
20.3K
Pharmacological Tests in Atrial Fibrillation Ablation
Jean-Baptiste Gourraud1, Jason G Andrade1, Laurent Macle1
1Electrophysiology Service, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.
Arrhythmia & Electrophysiology Review
|January 25, 2017
Summary
Pulmonary vein ablation is standard for atrial fibrillation (AF). Pharmacological adjuncts may improve outcomes by addressing ablation failures and identifying non-pulmonary vein triggers.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Atrial fibrillation (AF) management has evolved with pulmonary vein antrum ablation as a standard treatment.
- Long-term success is limited by incomplete lesion creation and unidentified arrhythmia triggers.
Purpose of the Study:
- To review the mechanisms and evidence for using pharmacological adjuncts during AF catheter ablation.
- To explore strategies for improving AF ablation outcomes.
Main Methods:
- Review of existing literature on pharmacological interventions in AF ablation.
- Analysis of mechanisms of action for suggested pharmacological adjuncts.
- Evaluation of clinical evidence supporting their use in paroxysmal and persistent AF.
Main Results:
- Pharmacological challenges may enhance the effectiveness of catheter ablation.
- Identifying and targeting non-pulmonary vein triggers remains crucial for long-term success.
- Evidence suggests potential benefits for specific pharmacological agents.
Conclusions:
- Pharmacological adjuncts represent a promising strategy to improve AF ablation outcomes.
- Further research is needed to optimize their application and confirm long-term efficacy.
- Integrating pharmacological approaches may overcome current limitations in AF management.
Related Concept Videos
01:30Dysrhythmias V: Evaluating Dysrhythmias
429
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
429
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.8K
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
753
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
753